Is there any association of apolipoprotein E gene polymorphism with obesity status and lipid profiles? Tehran Lipid and Glucose Study (TLGS)

Gene

Volumn 509, Issue 2, 2012, Pages 282-285

  Zarkesh, Maryam ^a   Daneshpour, Maryam S ^a   Faam, Bita ^a   Hedayati, Mehdi ^a   Azizi, Fereidoun ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Abdominal obesity; Apo lipoprotein E; Gene polymorphism; Tehran

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; IRAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; WAIST CIRCUMFERENCE;

ADULT; AGE FACTORS; ALLELES; APOLIPOPROTEINS E; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE; HUMANS; IRAN; LIPIDS; MALE; OBESITY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES;

EID: 84866373453     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.07.048     Document Type: Article

References (25)

1. Alberti K.G., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
2. Alvim R.O., et al. APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population. Lipids Health Dis. 2010, 9:128.
3. Azizi F., et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials 2009, 25:10-15.
4. Bisgaier C.L., Sachdev O.P., Megna L., Glickman R.M. Distribution of apolipoprotein A-IV in human plasma. J. Lipid Res. 1985, 26:11-25.
5. Chaaba R., et al. Association Between Apolipoprotein E Polymorphism, Lipids, and Coronary Artery Disease in Tunisian Type 2 Diabetes 2008.
6. Comuzzie A.G., Allison D.B. The search for human obesity genes. Science 1998, 280:1374-1377.
7. Dallongeville J., Lussier-Cacan S., Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J. Lipid Res. 1992, 33:447-454.
8. Daneshpour M.S., Hedayati M., Eshraghi P., Hooshmand M., Azizi F. Asociation of apolipoprotein E gene polymorphism and lipid level in an Iranian population: Tehran lipid and glucose study. Iranian J. Diabetes Lipid 2008, 7:399-405.
9. Daneshpour M., Hedayati M., Eshraghi P., Azizi F. Association of Apo E gene polymorphism with HDL level in a Thehranian population. Eur. J. Lipid Sci. Technol. 2010, 112:810-816.
10. Delavari A., Forouzanfar M.H., Alikhani S., Sharifian A., Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care 2009, 32:1092-1097.
11. Haddy N., et al. The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe. Eur. J. Hum. Genet. 2002, 10:841-850.
12. Kolovou G.D., et al. Apolipoprotein E gene polymorphism and obesity status in middle-aged men with coronary heart disease. In Vivo 2009, 23:33-39.
13. Kopelman P.G. Obesity as a medical problem. Nature 2000, 404:635-643.
14. Liu K., Muse S.V. PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 2005, 21:2128-2129.
15. Muros M., Rodri?guez-Ferrer C. Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4. Atherosclerosis 1996, 121:13-21.
16. Mutch D.M., Clement K. Genetics of human obesity. Best Pract. Res. Clin. Endocrinol. Metab. 2006, 20:647-664.
17. Nascimento H., et al. Lipid profile in Portuguese obese children and adolescents: interaction of apolipoprotein E polymorphism with adiponectin levels. Arch. Pediatr. Adolesc. Med. 2009, 163:1030-1036.
18. NCEP Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285:2486-2497.
19. Rankinen T., et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring) 2006, 14:529-644.
20. Ruesten A., et al. Trend in obesity prevalence in European adult cohort populations during follow-up since 1996 and their predictions to 2015. PLoS One 2011, 6:e27455.
21. Sing C.F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am. J. Hum. Genet. 1985, 37:268-285.
22. Talmud P.J. Gene-environment interaction and its impact on coronary heart disease risk. Nutr. Metab. Cardiovasc. Dis. 2007, 17:148-152.
23. Truett G.E., Heeger P., Mynatt R.L., Truett A.A., Walker J.A., Warman M.L. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 2000, 29(52):54.
24. Wildman R.P., Gu D., Reynolds K., Duan X., Wu X., He J. Are waist circumference and body mass index independently associated with cardiovascular disease risk in Chinese adults?. Am. J. Clin. Nutr. 2005, 82:1195-1202.
25. Zeljko H.M., et al. E2 allele of the apolipoprotein E gene polymorphism is predictive for obesity status in Roma minority population of Croatia. Lipids Health Dis. 2011, 10:9.